menu
    • menu

    Company profile for Amneal Deutschland GmbH

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Since 01. May 2019, Amneal Germany has been part of Ever Pharma Holding GmbH. EVER Pharma is a pharmaceutical specialist focused on research, development, manufacturing and marketing of neurology, critical care, anesthesia and oncology products. With 25 international affiliates and strategic partners, the products are marketed in more than 70 countries worldwide. Our team of product development, regulatory affairs, logistics, ...
    Since 01. May 2019, Amneal Germany has been part of Ever Pharma Holding GmbH. EVER Pharma is a pharmaceutical specialist focused on research, development, manufacturing and marketing of neurology, critical care, anesthesia and oncology products. With 25 international affiliates and strategic partners, the products are marketed in more than 70 countries worldwide. Our team of product development, regulatory affairs, logistics, customer service, sales and marketing professionals work closely together to ensure that we deliver a level of service to our partners that is matched by the exceptional overall offering we offer Is consistent.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Amneal Deutschland GmbHGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Oppelner Str. 582194 Gröbenzell
    Telephone
    Telephone
    +49 8142 42 22 50
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://amneal.de/ueber-amneal/amneal-deutschland/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amneal Eu’s Generics Plerixafor Receives Approvals In US
    Amneal Eu’s Generics Plerixafor Receives Approvals In US

    28 Oct 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215334

    FDA
    28 Oct 2021
    Share Share
    Amneal's Generic Methylprednisolone Receives Approval In US
    Amneal's Generic Methylprednisolone Receives Approval In US

    21 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207481

    FDA
    21 Sep 2021
    Share Share
    Amneal Receives Approval for Generic TobraDex
    Amneal Receives Approval for Generic TobraDex

    19 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210719005791/en/Amneal-Receives-Approval-for-Generic-TobraDex%C2%AE

    BUSINESSWIRE
    19 Jul 2021
    Share Share
    Amneal's Generic Apremilast (10mg, 20mg and 30mg) Receives Approval in the U.S
    Amneal's Generic Apremilast (10mg, 20mg and 30mg) Receives Approval in the U.S

    30 Jun 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211782

    FDA
    30 Jun 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search